Literature DB >> 3492167

Trimethoprim-sulfamethoxazole desensitization in the acquired immunodeficiency syndrome.

R M Smith, G K Iwamoto, H B Richerson, J P Flaherty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3492167     DOI： 10.7326/0003-4819-106-2-335_1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

Review 1.  Prophylaxis against opportunistic infections in patients infected with the human immunodeficiency virus.

Authors:  L W Cheever; R E Chaisson; J E Gallant
Journal:  West J Med       Date:  1996 Jul-Aug

2.  Diagnosis and Treatment of Toxoplasmosis of the CNS in Patients with AIDS.

Authors:  C Katlama
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

3.  Trimethoprim-sulfamethoxazole desensitization in AIDS.

Authors:  G Papakonstantinou; H Füessl; R Hehlmann
Journal:  Klin Wochenschr       Date:  1988-04-15

Review 4.  Current recommendations and future prospects in the treatment of toxoplasmosis.

Authors:  R E McCabe; S Oster
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

Review 5.  Adverse effects of drugs used in the management of opportunistic infections associated with HIV infection.

Authors:  B S Peters; E Carlin; R J Weston; S J Loveless; J Sweeney; J Weber; J Main
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 6.  Management of cutaneous drug reactions.

Authors:  K S Babu; Geeta Belgi
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.919

Review 7.  Pneumocystis jirovecii colonization in Chronic Obstructive Pulmonary Disease (COPD).

Authors:  S Khodavaisy; E Mortaz; F Mohammadi; M Aliyali; H Fakhim; H Badali
Journal:  Curr Med Mycol       Date:  2015-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.